Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-28 Purchase | 2024-08-30 4:16 pm | Inhibrx Biosciences Inc. | INBX | MANHARD KIMBERLY Director | 10,000 | $13.98 | $139,800 | 10,000 (Indirect) | View |
| 2022-05-03 Sale | 2022-05-04 7:01 pm | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,504 | $4.7564 | $7,154 | 12,376 (Direct) | View |
| 2021-05-03 Sale | 2021-05-04 6:03 pm | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,529 | $17.66 | $27,009 | 3,163 (Direct) | View |
| 2020-12-22 Sale | 2020-12-23 4:23 pm | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 10,000 | $20 | $200,000 | 48,416 (Direct) | View |
| 2020-05-01 Sale | 2020-05-01 6:48 pm | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY Executive VP, Drug Development | 1,158 | $13.97 | $16,176 | 1,158 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Disposition | 2024-05-30 6:23 pm | N/A 2030-10-02 | Inhibrx Inc. | INBX | MANHARD KIMBERLY Director | 65,759 | $0 | 0 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-30 6:11 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INXB | MANHARD KIMBERLY Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 4:08 pm | N/A 2033-05-25 | Inhibrx Inc. | INBX | MANHARD KIMBERLY Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-04-13 Tax Withholding | 2023-04-17 5:26 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,417 | $2.88 | 63,766 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-17 5:26 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 63,766 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 5:08 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 149,365 | $0 | 149,365 (Direct) | View |
| 2023-01-13 Tax Withholding | 2023-01-17 5:34 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 2,012 | $3.17 | 66,838 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-17 5:34 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 66,838 (Direct) | View |
| 2022-10-31 Other | 2023-01-17 5:34 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,655 | $3.2725 | 66,838 (Direct) | View |
| 2022-10-13 Tax Withholding | 2022-10-17 4:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 2,012 | $3.76 | 65,540 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 4:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 65,540 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 6:21 pm | N/A 2032-07-25 | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 165,961 | $0 | 165,961 (Direct) | View |
| 2022-07-13 Exercise | 2022-07-15 4:55 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 67,552 (Direct) | View |
| 2022-07-13 Tax Withholding | 2022-07-15 4:55 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 2,012 | $3.01 | 67,552 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:31 pm | N/A 2032-05-25 | Inhibrx Inc. | INBX | MANHARD KIMBERLY Director | 15,000 | $0 | 50,759 (Direct) | View |
| 2022-04-29 Other | 2022-05-04 7:01 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,504 | $3.842 | 12,376 (Direct) | View |
| 2022-04-13 Exercise | 2022-04-15 5:03 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 69,564 (Direct) | View |
| 2022-04-13 Tax Withholding | 2022-04-15 5:03 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 2,012 | $6.07 | 69,564 (Direct) | View |
| 2022-01-13 Tax Withholding | 2022-01-14 5:05 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 2,012 | $8.3 | 71,576 (Direct) | View |
| 2022-01-13 Exercise | 2022-01-14 5:05 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 71,576 (Direct) | View |
| 2021-10-13 Exercise | 2021-10-15 4:22 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,250 | $0 | 165,788 (Direct) | View |
| 2021-10-13 Tax Withholding | 2021-10-15 4:22 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 433 | $10.55 | 165,788 (Direct) | View |
| 2021-10-13 Option Award | 2021-10-15 4:22 pm | N/A 2031-10-13 | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 147,520 | $0 | 165,788 (Direct) | View |
| 2021-07-13 Tax Withholding | 2021-07-15 4:47 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 433 | $13.48 | 18,701 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 4:47 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,250 | $0 | 18,701 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-08 5:19 pm | N/A 2031-06-07 | Inhibrx Inc. | INBX | MANHARD KIMBERLY Director | 15,000 | $0 | 35,759 (Direct) | View |
| 2021-04-30 Other | 2021-05-04 6:03 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,529 | $13.9 | 3,163 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 4:51 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,250 | $0 | 19,134 (Direct) | View |
| 2021-04-13 Tax Withholding | 2021-04-15 4:51 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 433 | $16.66 | 19,134 (Direct) | View |
| 2021-01-13 Tax Withholding | 2021-01-15 4:25 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 433 | $18.16 | 19,567 (Direct) | View |
| 2021-01-13 Exercise | 2021-01-15 4:25 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,250 | $0 | 19,567 (Direct) | View |
| 2020-12-22 Exercise | 2020-12-23 4:23 pm | N/A 2026-12-21 | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 10,000 | $0 | 48,416 (Direct) | View |
| 2020-12-22 Exercise | 2020-12-23 4:23 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 10,000 | $13 | 48,416 (Direct) | View |
| 2020-10-13 Option Award | 2020-10-15 4:25 pm | N/A 2030-10-13 | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 140,000 | $0 | 140,000 (Direct) | View |
| 2020-08-21 Option Award | 2020-08-21 4:24 pm | N/A 2030-08-20 | Inhibrx Inc. | INBX | MANHARD KIMBERLY Director | 17,259 | $0 | 17,259 (Direct) | View |
| 2020-04-30 Other | 2020-05-01 6:48 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY Executive VP, Drug Development | 1,158 | $12.12 | 1,158 (Direct) | View |